NCT03654703View on ClinicalTrials.gov

Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML

PHASE2UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2015

Primary Completion Date

July 1, 2018

Study Completion Date

March 1, 2020

Conditions
Hematopoietic System--Cancer
Interventions
DRUG

Cyclophosphamide

cyclophophamide

Trial Locations (1)

100020

Yan Yue, Beijing

Sponsors
All Listed Sponsors
lead

Capital Research Institute of Pediatrics

OTHER_GOV